Systemic sclerosis (scleroderma) treatment options

Systemic sclerosis, also called scleroderma, is a disabling disease in which a patient’s soft tissues become hardened by fibrosis. This can affect skin, muscles, vital internal organs, and blood vessels. Most patients also experience numbness in their extremities and intensified reactions to cold and to anxiety. The cause of scleroderma is believed to be auto-immunological. There is no established cure.
It’s believed that some 1,500,00 women and 500,000 men suffer from systemic sclerosis, but the figures are uncertain because most cases in the past have gone undiagnosed. Due to the nature of the disease’s effects, orthopedic surgeons have seen most cases in order to treat the shortening of muscles and tendons, to remove dead tissue, and to amputate infected extremities. As the disease has become better known, patients are being referred to rheumatologists familiar with autoimmune diseases.
Chemotherapy utilizing intravenous cyclophosphamide, an immunosuppressive drug, has offered some improvement. But the greatest hope is being offered by the infusion of autologous hematopoietic stem cells, a technique that ProgenCell pioneered at the turn of this century. The good news has been reported in the Grand Rapids Press and in USA Today.
In 2011, a stem cell therapy almost identical to ProgenCell’s own was tested clinically at Duke University in North Carolina. Patients from that trial talk about their experiences on this eye-opening video:
[youtube http://www.youtube.com/watch?v=rthIgDjjALU?rel=0]
If you suffer from scleroderma, you don’t have to hope for another clinical trial in the United States. Help is already available just a few minutes south of San Diego, California. You can begin your recovery today by contacting ProgenCell for a complimentary evaluation of your case.

Facebook Comments

About the Author :

START TYPING AND PRESS ENTER TO SEARCH